Drug Development

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Articles

Three-dimensional printing allows unique benefits to be built in to solid-dosage forms.

Using 3D Printing for Solid-Dosage Drugs

A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.

Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

A Q&A with FDA to gain insight on FDA's views of three-dimensional printing and its regulation in drug manufacturing.

FDA and the Emerging Technology of 3D Printing

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Industry experts discuss key considerations in the development of orally disintegrating tablets.

A Case for Orally Disintegrating Tablets

An MIT-developed system uses microbes for manufacturing small amounts of vaccines and other therapies.

Portable Device Delivers Biopharmaceuticals on Demand

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Amgen discussed the drug-delivery approaches to two of its biologics in a recent second-quarter earnings call.

Amgen: Neulasta Safe for Now; Dose Accuracy of Erenumab a New Focus

NIST’s monoclonal antibody reference material can be used as a standard for biopharmaceutical analytical quality control.

NIST Issues mAb Reference Standard

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA and industry seek speedy Congressional approval of new user fee plan.

The Industry Hopes Congress Approves PDUFA Program in 2016

The Phase I trial will test Bavarian Nordic’s vaccine, which is manufactured using a vaccine vector based on smallpox.The recent resurgence of yellow fever incidences over the past six months has prompted health officials to ramp up the fight against the virus. Like the Zika virus, yellow fever is transmitted primarily through the bite of infected female Aedes aegypti mosquitoes.

NIH-Backed Yellow Fever Vaccine Trial Announced

The affinity purification company will set up shop at the former Merck & Co./GlycoFi facility in the Dartmouth Regional Technology Center in New Hampshire.

Formulation and Drug Delivery